The DOI matches its Crossref record; 550 of the 550 references it cites were found in a registry or an index.
Organic Cation Transporters in Health and Disease
Abstract
The organic cation transporters (OCTs) OCT1, OCT2, OCT3, novel OCT (OCTN)1, OCTN2, multidrug and toxin exclusion (MATE)1, and MATE kidney-specific 2 are polyspecific transporters exhibiting broadly overlapping substrate selectivities. They transport organic cations, zwitterions, and some uncharged compounds and operate as facilitated diffusion systems and/or antiporters. OCTs are critically involved in intestinal absorption, hepatic uptake, and renal excretion of hydrophilic drugs. They modulate the distribution of endogenous compounds such as thiamine, L-carnitine, and neurotransmitters. Sites of expression and functions of OCTs have important impact on energy metabolism, pharmacokinetics, and toxicity of drugs, and on drug–drug interactions. In this work, an overview about the human OCTs is presented. Functional properties of human OCTs, including identified substrates and inhibitors of the individual transporters, are described. Sites of expression are compiled, and data on regulation of OCTs are presented. In addition, genetic variations of OCTs are listed, and data on their impact on transport, drug treatment, and diseases are reported. Moreover, recent data are summarized that indicate complex drug–drug interaction at OCTs, such as allosteric high-affinity inhibition of transport and substrate dependence of inhibitor efficacies. A hypothesis about the molecular mechanism of polyspecific substrate recognition by OCTs is presented that is based on functional studies and mutagenesis experiments in OCT1 and OCT2. This hypothesis provides a framework to imagine how observed complex drug–drug interactions at OCTs arise. Finally, preclinical in vitro tests that are performed by pharmaceutical companies to identify interaction of novel drugs with OCTs are discussed. Optimized experimental procedures are proposed that allow a gapless detection of inhibitory and transported drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–550 of 550
Fine Mapping and Functional Analysis Reveal a Role of SLC22A1 in Acylcarnitine Transport
Kim, H. I., Raffler, J., Lu, W., Lee, J., Abbey, D., Saleheen, D., Rabinowitz, J. D., Bennett, M. J., Hand, N. J., Brown, C. D., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.08.008 · Cited by 66
Liang, X., Yee, S. W., Chien, H., Chen, E. C., Luo, Q., Zou, L., Piao, M., Mifune, A., Chen, L., Calvert, M., et al. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2002907 · Cited by 66
Sun, S., Wang, K., Lei, H., Li, L., Tu, M., Zeng, S., Zhou, H., & Jiang, H. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.11.005 · Cited by 65
Decreased anxiety in mice lacking the organic cation transporter 3
Wultsch, T., Grimberg, G., Schmitt, A. G., Painsipp, E., Wetzstein, H., Breitenkamp, A. F., Gründemann, D., Schömig, E., Lesch, K., Gerlach, M., et al. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0205-1 · Cited by 65
Inhibition of OCTN2-Mediated Transport of Carnitine by Etoposide
Hu, C., Lancaster, C. S., Zuo, Z., Hu, S., Chen, Z., Rubnitz, J. E., Baker, S. D., & Sparreboom, A. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0980 · Cited by 65
Lee, W.-K., Reichold, M., Edemir, B., Ciarimboli, G., Warth, R., Koepsell, H., & Thévenod, F. (2009) · AJP - Renal Physiology · doi:10.1152/ajprenal.90754.2008 · Cited by 65
Self-citationKancko, A., Bergqvist, Y., Taleo, G. K., Kobayakawa, T., Ishizaki, T., & rkman, A. B. (1999) · Pharmacogenetics · doi:10.1097/00008571-199906000-00006 · Cited by 64
Common Drugs Inhibit Human Organic Cation Transporter 1 (OCT1)-Mediated Neurotransmitter Uptake
Boxberger, K. H., Hagenbuch, B., & Lampe, J. N. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.055095 · Cited by 64
Rare mutations associating with serum creatinine and chronic kidney disease
Sveinbjörnsson, G., Mikaelsdottir, E., Pálsson, R., Indridason, Ó. S., Hólm, H., Jónasdóttir, Á., Helgason, A., Sigurðsson, S., Jónasdóttir, A., Sigurðsson, Á., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu399 · Cited by 64
OCTN1 Is a High-Affinity Carrier of Nucleoside Analogues
Drenberg, C. D., Gibson, A. A., Pounds, S. B., Shi, L., Rhinehart, D. P., Li, L., Hu, S., Du, G., Nies, A. T., Schwab, M. G., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2548 · Cited by 64
Ribas, G. S., Manfredini, V., de Marco, M. G., Vieira, R. B., Wayhs, C. A. Y., Vanzin, C. S., Biancini, G. B., Wajner, M., & Vargas, C. R. (2010) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2010.07.008 · Cited by 63
Chen, E. C., Khuri, N., Liang, X., Stecuła, A., Chien, H., Yee, S. W., Huang, Y. L., Šali, A., & Giacomini, K. M. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01317 · Cited by 63
Metformin targets brown adipose tissue in vivo and reduces oxygen consumption in vitro
Breining, P., Jensen, J., Sundelin, E. I. O., Gormsen, L. C., Jakobsen, S., Busk, M., Rolighed, L., Bross, P., Guerra, P. F., Markussen, L. K., et al. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13362 · Cited by 63
Single dose pharmacokinetics of proguanil and its metabolites in healthy subjects.
Wattanagoon, Y., Taylor, R. B., Moody, R., Ochekpe, N., Looareesuwan, S., & White, N. J. (1987) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1987.tb03245.x · Cited by 62
Tu, M., Sun, S., Wang, K., Peng, X., Wang, R., Li, L., Zeng, S., Zhou, H., & Jiang, H. (2013) · Toxicology · doi:10.1016/j.tox.2013.06.009 · Cited by 62
Brain organic cation transporter 2 controls response and vulnerability to stress and GSK3β signaling
Couroussé, T., Bacq, A., Belzung, C., Guiard, B. P., Balasse, L., Louis, F., Guisquet, A.-M. L., Gardier, A. M., Schinkel, A. H., Giros, B., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.86 · Cited by 62
Steady-State Pharmacokinetics of Metformin Is Independent of the OCT1 Genotype in Healthy Volunteers
Christensen, M. M. H., Højlund, K., Hother-Nielsen, O., Stage, T. B., Damkier, P., Beck-Nielsen, H., & Brøsen, K. (2015) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-015-1853-8 · Cited by 62
Nies, A. T., Schaeffeler, E., van der Kuip, H., Cascorbi, I., Bruhn, O., Kneba, M., Pott, C., Hofmann, U., Volk, C., Hu, S., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1999 · Cited by 61
Self-citationCharacterization of the human MATE2 proton-coupled polyspecific organic cation exporter
Komatsu, T., Hiasa, M., Miyaji, T., Kanamoto, T., Matsumoto, T., Otsuka, M., Moriyama, Y., & Omote, H. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.03.005 · Cited by 61
Kato, K., Mori, H., Kito, T., Yokochi, M., Ito, S., Inoue, K., Yonezawa, A., Katsura, T., Kumagai, Y., Yuasa, H., et al. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1144-y · Cited by 61
Gorbunov, D., Gorboulev, V., Shatskaya, N. V., Mueller, T. D., Bamberg, E., Friedrich, T., & Koepsell, H. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.040170 · Cited by 61
Self-citationUmehara, K., Iwatsubo, T., Noguchi, K., & Kamimura, H. (2007) · Xenobiotica · doi:10.1080/00498250701546012 · Cited by 60
Wang, C., Uray, I. P., Mazumdar, A., Mayer, J. A., & Brown, P. H. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1925-0 · Cited by 59
OCT1 and imatinib transport in CML: is it clinically relevant?
Watkins, D. B., Hughes, T. P., & White, D. L. (2015) · Leukemia · doi:10.1038/leu.2015.170 · Cited by 58
Gupta, S., Wulf, G. G., Henjakovic, M., Koepsell, H., Burckhardt, G., & Hagos, Y. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.190561 · Cited by 57
Self-citationMinematsu, T., Iwai, M., Umehara, K., Usui, T., & Kamimura, H. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.028142 · Cited by 57
A missense mutation in the OCTN2 gene associated with residual carnitine transport activity
Wang, Y., Kelly, M. A., Cowan, T. M., & Longo, N. (2000) · Human Mutation · Cited by 56
Functional Genetic Diversity in the High-Affinity Carnitine Transporter OCTN2 (SLC22A5)
Urban, T. J., Gallagher, R. C., Brown, C., Castro, R. A., Lagpacan, L. L., Brett, C. M., Taylor, T. R., Carlson, E. J., Ferrin, T. E., Burchard, E. G., et al. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.028126 · Cited by 56
Song, I., Shin, H. J., & Shin, J. (2008) · Xenobiotica · doi:10.1080/00498250802130039 · Cited by 56
Taubert, D., Grimberg, G., Jung, N., Rubbert, A., & Schömig, E. (2005) · Gut · doi:10.1136/gut.2005.076083 · Cited by 55
Organic cation transporter 3 contributes to norepinephrine uptake into perivascular adipose tissue
Ayala‐Lopez, N., Jackson, W. F., Burnett, R. J., Wilson, J. N., Thompson, J., & Watts, S. W. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00308.2015 · Cited by 55
Fink, M. A., Paland, H., Herzog, S., Grube, M., Vogelgesang, S., Weitmann, K., Bialke, A., Hoffmann, W. U., Rauch, B. H., Schroeder, H. W. S., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2380 · Cited by 55
Urban, T. J., Yang, C., Lagpacan, L. L., Brown, C., Castro, R. A., Taylor, T. R., Huang, C. C., Stryke, D., Johns, S. J., Kawamoto, M., et al. (2007) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3281c6d08e · Cited by 54
Brazier, L., Tiret, L., Luc, G., Arveiler, D., Ruidavets, J. B., Evans, A., Chapman, J., Cambien, F., & Thillet, J. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00333-5 · Cited by 54
An unsuspected role for organic cation transporter 3 in the actions of amphetamine
Mayer, F. P., Schmid, D., Owens, W. A., Gould, G. G., Apuschkin, M., Kudlacek, O., Salzer, I., Boehm, S., Chiba, P., Williams, P., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0053-5 · Cited by 54
Functional Analysis of Human Organic Cation Transporter OCT3 (SLC22A3) Polymorphisms
Sakata, T., Anzai, N., Kimura, T., Miura, D., Fukutomi, T., Takeda, M., Sakurai, H., & Endou, H. (2010) · Journal of Pharmacological Sciences · doi:10.1254/jphs.09331sc · Cited by 53
Kitaichi, K., Fukuda, M., Nakayama, H., et al. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.03.014 · Cited by 53
Al‐Abdulla, R., Lozano, E., Macías, R. I. R., Monte, M. J., Briz, Ó., O’Rourke, C. J., Serrano, M. A., Bañales, J. M., Avila, M. A., Martínez‐Chantar, M. L., et al. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14563 · Cited by 53
Song, W., Luo, Q., Zhang, Y., Zhou, L., Liu, Y., Ma, Z., Guo, J., Huang, Y., Cheng, L., Meng, Z., et al. (2019) · PLoS Biology · doi:10.1371/journal.pbio.2006571 · Cited by 53
The localisation of the extraneuronal monoamine transporter (EMT) in rat brain
Haag, C., Berkels, R., Gründemann, D., Lazar, A., Taubert, D., & Schömig, E. (2003) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02180.x · Cited by 52
Gasser, P. J., Hurley, M. M., Chan, J., & Pickel, V. M. (2017) · Brain Structure and Function · doi:10.1007/s00429-016-1315-9 · Cited by 52
Characterization of organic cation/carnitine transporter family in human sperm
Xuan, W., Lamhonwah, A., Librach, C. L., Jarvi, K. A., & Tein, I. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00930-6 · Cited by 51
Leung, E. Y., Hong, J., Fraser, A. G., Merriman, T. R., Vishnu, P., & Krissansen, G. W. (2006) · Immunology and Cell Biology · doi:10.1111/j.1440-1711.2006.01423.x · Cited by 51
Vée, M. L., Lecureur, V., Moreau, A., Stieger, B., & Fardel, O. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.028035 · Cited by 51
Interaction of beta‐blockers with the renal uptake transporter OCT2
Bachmakov, I., Glaeser, H., Endreß, B., Mörl, F., König, J., & Fromm, M. F. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01076.x · Cited by 50
Toyama, K., Yonezawa, A., Tsuda, M., et al. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328335639f · Cited by 50
Interactions of Organic Anion Transporters and Organic Cation Transporters With Mycotoxins
Tachampa, K., Takeda, M., Khamdang, S., Noshiro, R., Tsuda, M., Jariyawat, S., Fukutomi, T., Sophasan, S., Anzai, N., & Endou, H. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0070911 · Cited by 50
Transport of guanidine compounds by human organic cation transporters, hOCT1 and hOCT2
Kimura, N., Masuda, S., Katsura, T., & Inui, K. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.01.010 · Cited by 49
Peng, X., Gennemark, P., O’Mahony, G., & Bartesaghi, S. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00174 · Cited by 49
OCT1 Genetic Variants are Associated with Postoperative Morphine-Related Adverse Effects in Children
Balyan, R., Zhang, X., Chidambaran, V., Martin, L. J., Mizuno, T., Fukuda, T., Vinks, A. A. T. M. M., & Sadhasivam, S. (2017) · Pharmacogenomics · doi:10.2217/pgs-2017-0002 · Cited by 49
Koepsell, H. (2018) · Biological Chemistry · doi:10.1515/hsz-2018-0191 · Cited by 49
Self-citationItoda, M., Saito, Y., Maekawa, K., Hichiya, H., Komamura, K., Kamakura, S., Kitakaze, M., Tomoike, H., Ueno, K., Ozawa, S., et al. (2004) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.19.308 · Cited by 48
Lazar, A., Walitza, S., Jetter, A., Gerlach, M., Warnke, A., Herpertz‐Dahlmann, B., Gründemann, D., Grimberg, G., Schulz, E., Remschmidt, H., et al. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007742 · Cited by 48
Contribution of OCTN Variants Within the IBD5 Locus to Pediatric Onset Crohn's Disease
Babusukumar, U., Wang, T., McGuire, E., Broeckel, U., & Kugathasan, S. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00564.x · Cited by 48
Critical roles of Sp1 in gene expression of human and rat H+/organic cation antiporter MATE1
Kajiwara, M., Terada, T., Asaka, J., Ogasawara, K., Katsura, T., Ogawa, O., Fukatsu, A., Doi, T., & Inui, K. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00322.2007 · Cited by 48
Involvement of Organic Cation Transporters in the Kinetics of Trimethylamine N-oxide
Miyake, T., Mizuno, T., Mochizuki, T., Kimura, M., Matsuki, S., Irie, S., Ieiri, I., Maeda, K., & Kusuhara, H. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.04.067 · Cited by 48
Luminal transport system for H+/organic cations in the rat proximal tubule
David, C., Rumrich, G., & Ullrich, K. J. (1995) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00373884 · Cited by 47
Yin, J., Duan, H., & Wang, J. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.236158 · Cited by 47
Cai, H., Zhang, Y., Han, T. K., Everett, R. S., & Thakker, D. R. (2016) · International Journal of Cancer · doi:10.1002/ijc.29965 · Cited by 46
Relationship between proguanil metabolic ratio and CYP2C19 genotype in a Caucasian population
Hoskins, J. M., Shenfield, G. M., & Gross, A. S. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00807.x · Cited by 46
MATE1 has an external COOH terminus, consistent with a 13-helix topology
Zhang, X., & Wright, S. H. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00123.2009 · Cited by 46
Massmann, V., Edemir, B., Schlatter, E., Al-Monajjed, R., Harrach, S., Klassen, P., Holle, S. K., Sinđić, A., Dobrivojević, M., Pavenstädt, H. J., et al. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-013-1335-8 · Cited by 46
Cimetidine Reduces Procainamide Elimination
Somogyi, A. A., & Heinzow, B. (1982) · New England Journal of Medicine · doi:10.1056/nejm198210213071715 · Cited by 46
Santiago, J. L., Martínez, A., de la Calle, H., Fernández‐Arquero, M., Figueredo, M. A., de la Concha, E. G., & Urcelay, E. (2006) · BMC Medical Genetics · doi:10.1186/1471-2350-7-54 · Cited by 45
Kobayashi, D., Aizawa, S., Maeda, T., Tsuboi, I., Yabuuchi, H., Nezu, J., Tsuji, A., & Tamai, I. (2004) · Experimental Hematology · doi:10.1016/j.exphem.2004.08.009 · Cited by 45
Substrate-Dependent Inhibition of Human MATE1 by Cationic Ionic Liquids
Martinez-Guerrero, L., & Wright, S. H. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.204206 · Cited by 45
Relative Carnitine Insufficiency in Children With Type I Diabetes Mellitus
Winter, S. C., Simon, M., Zorn, E. M., Szabo-Aczel, S., Vance, W. H., O'Hara, T., & Higashi, L. (1989) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1989.02150230095030 · Cited by 45
Organic cation transporter mRNA and function in the rat superior cervical ganglion
Kristufek, D., Rudorfer, W., Pifl, C., & Huck, S. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.021170 · Cited by 45
Rulcová, A., Krausová, L., Smutný, T., Vrzal, R., Dvořák, Z., Jover, R., & Pávek, P. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71491-9 · Cited by 44
RS1 (RSC1A1) regulates the exocytotic pathway of Na+- d -glucose cotransporter SGLT1
Veyhl, M., Keller, T., Gorboulev, V., Vernaleken, A., & Koepsell, H. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00068.2006 · Cited by 44
Self-citationD’Argenio, G., Petillo, O., Margarucci, S., Torpedine, A., Calarco, A., Koverech, A., Boccia, A. S., Paolella, G., & Peluso, G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.109678 · Cited by 43
Li, L., Tu, M., Yang, X., Sun, S., Wu, X., Zhou, H., Zeng, S., & Jiang, H. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.056689 · Cited by 43
Mooij, M. G., van de Steeg, E., van Rosmalen, J., Windster, J. D., de Koning, B. A. E., Vaes, W. H. J., van Groen, B. D., Tibboel, D., Wortelboer, H. M., & de Wildt, S. N. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.068577 · Cited by 43
Contraluminal transport of organic cations in the proximal tubule of the rat kidney
Ullrich, K. J., Rumrich, G., Neiteler, K., & Fritzsch, G. (1992) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00378638 · Cited by 43
Matthaei, J., Seitz, T., Jensen, O., Tann, A., Prukop, T., Tadjerpisheh, S., Brockmöller, J., & Tzvetkov, M. V. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1128 · Cited by 43
Solbach, T. F., Grube, M., Fromm, M. F., & Zolk, O. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3182270783 · Cited by 42
Barton, A. C., Eyre, S., Bowes, J., Ho, P., John, S., & Worthington, J. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20877 · Cited by 42
Veyhl, M., Wagner, C. A., Gorboulev, V., Schmitt, B. M., Lang, F. J. W., & Koepsell, H. (2003) · The Journal of Membrane Biology · doi:10.1007/s00232-003-0626-y · Cited by 41
Self-citationMartínez, A., Martín, M. D. C., Mendoza, J. L., Taxonera, C., Díaz‐Rubio, M., de la Concha, E. G., & Urcelay, E. (2005) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201529 · Cited by 41
Kashi, Z., Mahrooz, A., Kianmehr, A., & Alizadeh, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151543 · Cited by 41
Newman, W. G., Wintle, R. F., Oene, M. V., Yazdanpanah, M., Owen, J., Johnson, B., Gu, X., Amos, C. I., Keystone, E. C., Rubin, L. A., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20854 · Cited by 40
Multiple drug transporters mediate the placental transport of sulpiride
Bai, M., Ma, Z., Sun, D., Zheng, C., Weng, Y., Yang, X., Jiang, T., & Jiang, H. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2008-8 · Cited by 40
Umehara, K., Iwatsubo, T., Noguchi, K., Usui, T., & Kamimura, H. (2008) · Xenobiotica · doi:10.1080/00498250802334409 · Cited by 39
Genetic variability of the extraneuronal monoamine transporter EMT (SLC22A3)
Lazar, A., Gründemann, D., Berkels, R., Taubert, D., Zimmermann, T., & Schömig, E. (2003) · Journal of Human Genetics · doi:10.1007/s10038-003-0015-5 · Cited by 39
Jiang, W., Prokopenko, O., Wong, L., Inouye, M., & Mirochnitchenko, O. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.15.6496-6508.2005 · Cited by 39
Emtricitabine is a substrate of MATE1 but not of OCT1, OCT2, P-gp, BCRP or MRP2 transporters
Reznicek, J., Čečková, M., Červený, L., Müller, F., & Štaud, F. (2016) · Xenobiotica · doi:10.3109/00498254.2016.1158886 · Cited by 39
Multiple SLC and ABC Transporters Contribute to the Placental Transfer of Entecavir
Ma, Z., Yang, X., Jiang, T., Bai, M., Zheng, C., Zeng, S., Sun, D., & Jiang, H. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.073304 · Cited by 39
Tahara, H., Yee, S. W., Urban, T. J., Hesselson, S., Castro, R. A., Kawamoto, M., Stryke, D., Johns, S. J., Ferrin, T. E., Kwok, P., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.146449 · Cited by 38
McBride, B. F., Yang, T., Liu, K., Urban, T. J., Giacomini, K. M., Kim, R. B., & Roden, D. M. (2009) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181abc288 · Cited by 38
Ohta, K., Inoue, K., Yasujima, T., et al. (2010) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3r59x · Cited by 38
Colistin is Substrate of the Carnitine/Organic Cation Transporter 2 (OCTN2, SLC22A5)
Visentin, M., Gai, Z., Torozi, A., Hiller, C., & Kullak-Ublick, G. A. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.117.077248 · Cited by 38
Human organic cation transporter 3 mediates the transport of antiarrhythmic drugs
Hasannejad, H., Takeda, M., Narikawa, S., Huang, X.-L., Enomoto, A., Taki, K., Niwa, T., Jung, S. H., Onozato, M. L., Tojo, A., et al. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.098 · Cited by 37
O'Brien, V. P., Bokelmann, K., Ramı́rez, J., Jobst, K., Ratain, M. J., Brockmöller, J., & Tzvetkov, M. V. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.206359 · Cited by 37
Berg, T., Hegelund-Myrbäck, T., Öckinger, J., Zhou, X.-H., Brännström, M., Hagemann-Jensen, M., Werkström, V., Seidegård, J., Grünewald, J., Nord, M., et al. (2018) · Respiratory Research · doi:10.1186/s12931-018-0760-9 · Cited by 37
Babál, P., Ruchko, M. V., Campbell, C. C., Gilmour, S. P., Mitchell, J. L. A., Olson, J. W., & Gillespie, M. N. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38743-9 · Cited by 36
Structural modeling of human organic cation transporters
Dakal, T. C., Kumar, R., & Ramotar, D. (2017) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2017.03.007 · Cited by 36
Wagner, D. J., Sager, J. E., Duan, H., Isoherranen, N., & Wang, J. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.074708 · Cited by 36
Purification and Functional Reconstitution of the Rat Organic Cation Transporter OCT1
Keller, T., Elfeber, M., Gorboulev, V., Reiländer, H., & Koepsell, H. (2005) · Biochemistry · doi:10.1021/bi050676c · Cited by 34
Self-citationFunctional characterization of gefitinib uptake in non-small cell lung cancer cell lines
Galetti, M., Alfieri, R. R., Cavazzoni, A., Monica, S. L., Bonelli, M. A., Fumarola, C., Mozzoni, P., Palma, G. D., Andreoli, R., Mutti, A., et al. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.03.033 · Cited by 34
Bexten, M., Oswald, S., Grube, M., Jia, J., Graf, T., Zimmermann, U., Rodewald, K., Zolk, O., Schwantes, U., Siegmund, W., et al. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500532x · Cited by 34
Müller, F., Weitz, D., Mertsch, K., König, J., & Fromm, M. F. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00416 · Cited by 34
Boxberger, K. H., Hagenbuch, B., & Lampe, J. N. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.08.028 · Cited by 32
Characterization of Exosomal SLC22A5 (OCTN2) carnitine transporter
Console, L., Scalise, M., Tonazzi, A., Giangregorio, N., & Indiveri, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-22170-7 · Cited by 31
Wang, W., Bai, M., Jiang, T., Cui, L., Li, P., Zhou, H., Wang, Z., Li, L., & Jiang, H. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.11.007 · Cited by 31
Arduini, A., Mancinelli, G., Radatti, G., et al. (1992) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(92)90702-x · Cited by 30
Sorafenib Activity and Disposition in Liver Cancer Does Not Depend on Organic Cation Transporter 1
Chen, M., Neul, C., Schaeffeler, E., Frisch, F., Winter, S., Schwab, M. G., Koepsell, H., Hu, S., Laufer, S., Baker, S. D., et al. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1588 · Cited by 30
Self-citationModels of Affective Illness: Forced Swimming and Tail Suspension Tests in Rodents
Porsolt, R. D., Brossard, G., Hautbois, C., & Roux, S. (2000) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph0508s10 · Cited by 29
In vitro chemosensitivity of head and neck cancer cell lines
Schuler, P. J., Trellakis, S., Greve, J., et al. (2010) · European journal of medical research · doi:10.1186/2047-783x-15-8-337 · Cited by 29
Kawasaki, Y., Kato, Y., Sai, Y., & Tsuji, A. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20190 · Cited by 29
Multidrug and Toxic Compound Extrusion Protein-1 (MATE1/SLC47A1) Is a Novel Flavonoid Transporter
Lee, J. H., Lee, J. E., Kim, Y., Lee, H., Jun, H., & Lee, S. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf500916d · Cited by 29
Futatsugi, A., Masuo, Y., Kawabata, S., Nakamichi, N., & Kato, Y. (2016) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12574 · Cited by 29
Affinity of Ketamine to Clinically Relevant Transporters
Keiser, M., Hasan, M., & Oswald, S. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00627 · Cited by 29
Ferdinandusse, S., Brinke, H. T., Ruiter, J. P. N., Haasjes, J., Oostheim, W., van LENTHE, H., IJlst, L., Ebberink, M. S., Wanders, R. J. A., Vaz, F. M., et al. (2019) · Human Mutation · doi:10.1002/humu.23839 · Cited by 29
Nakayama, H., Kitaichi, K., Ito, Y., Hashimoto, K., Takagi, K., Yokoi, T., Takagi, K., Ozaki, N., Yamamoto, T., & Hasegawa, T. (2007) · Brain Research · doi:10.1016/j.brainres.2007.09.072 · Cited by 28
Imamura, Y., Murayama, N., Okudaira, N., Kurihara, A., Inoue, K., Yuasa, H., Izumi, T., Kusuhara, H., & Sugiyama, Y. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0890-6 · Cited by 28
Bacher, P., Giersiefer, S., Bach, M., Fork, C., Schömig, E., & Gründemann, D. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.09.019 · Cited by 27
Ohnishi, S., Okamura, N., Sakamoto, S. X., Hasegawa, H., Norikura, R., Kanaoka, E., Takahashi, K., Horie, K., Sakamoto, K., & Baba, T. (2008) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.23.293 · Cited by 27
Overview of SLC22A and SLCO Families of Drug Uptake Transporters in the Context of Cancer Treatments
Cutler, M. J., & Choo, E. F. (2011) · Current Drug Metabolism · doi:10.2174/138920011798357060 · Cited by 27
Role of SLC22A4, SLC22A5, and RUNX1 genes in rheumatoid arthritis.
Martínez, A., Valdivia, A., Pascual‐Salcedo, D., Balsa, A., Fernández‐Gutiérrez, B., la Concha, E. D., & Urcelay, E. (2006) · PubMed · Cited by 26
Cheng, Y., Wright, S. H., Hooth, M. J., & Sipes, I. G. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.022681 · Cited by 26
Xu, Y., Liu, X., Li, S., Zhou, N., Gong, L., Luo, C., Luo, X., Zheng, M., Jiang, H., & Chen, K. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400423g · Cited by 26
Cai, H., Everett, R. S., & Thakker, D. R. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14694 · Cited by 26
Qu, Q., Qu, J., Zhan, M., Wu, L., Zhang, Y., Lou, X.-Y., Fu, L., & Zhou, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076474 · Cited by 25
Saito, J., Hirota, T., Kikunaga, N., Otsubo, K., & Ieiri, I. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22595 · Cited by 25
Martinez-Guerrero, L., Morales, M. N., Ekins, S., & Wright, S. H. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.105056 · Cited by 25
Tatsumi, S., Matsuoka, H., Hashimoto, Y., Hatta, K., Maeda, K., & Kamoshida, S. (2014) · Europe PMC (PubMed Central) · Cited by 24
Sturm, A., Gorboulev, V., Gorbunov, D., Keller, T., Volk, C., Schmitt, B. M., Schlachtbauer, P., Ciarimboli, G., & Koepsell, H. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00106.2007 · Cited by 24
Self-citationImmuno-detection of OCTN1 (SLC22A4) in HeLa cells and characterization of transport function
Pochini, L., Scalise, M., & Indiveri, C. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.04.040 · Cited by 23
Veyhl-Wichmann, M., Friedrich, A., Vernaleken, A., Singh, S., Kipp, H., Gorboulev, V., Keller, T., Chintalapati, C., Pipkorn, R., Pastor‐Anglada, M., et al. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.101162 · Cited by 23
Self-citationMATE1 regulates cellular uptake and sensitivity to imatinib in CML patients
Harrach, S., Schmidt‐Lauber, C., Pap, T., Pavenstädt, H. J., Schlatter, E., Schmidt, E., Berdel, W. E., Schulze, U., Edemir, B., Jeromin, S., et al. (2016) · Blood Cancer Journal · doi:10.1038/bcj.2016.79 · Cited by 23
Genetic Variations of the SLC22A5 Gene in the Chinese and Indian Populations of Singapore
Toh, D. S. L., Yee, J. Y., Koo, S. H., Murray, M., & Lee, E. J. D. (2010) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.25.112 · Cited by 22
Management of treatment resistant obsessive-compulsive disorder. Algorithms for pharmacotherapy.
Albert, U., Bergesio, C., Pessina, E., et al. (2002) · PubMed · Cited by 21
Functional significance of conserved cysteines in the human organic cation transporter 2
Pelis, R. M., Dangprapai, Y., Cheng, Y., Zhang, X., Terpstra, J., & Wright, S. H. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00038.2012 · Cited by 20
Wagner, D. J., Shireman, L. M., Ahn, S., Shen, D. D., & Wang, J. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.082131 · Cited by 20
Impact of Organic Cation Transporters (OCT-SLC22A) on Differential Diagnosis of Intrahepatic Lesions
Visentin, M., van Rosmalen, B. V., Hiller, C., Bieze, M., Hofstetter, L., Verheij, J., Kullak-Ublick, G. A., Koepsell, H., Phoa, S. S. K. S., Tamai, I., et al. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.072371 · Cited by 19
Self-citationLiu, L., Zheng, Y., Li, H., & Qin, S. (2016) · Medicine · doi:10.1097/md.0000000000004993 · Cited by 18
Harrach, S., Edemir, B., Schmidt‐Lauber, C., Pap, T., Bertrand, J., & Ciarimboli, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-01438-4 · Cited by 18
Li, Q., Yang, H., Peng, X., Guo, D., Dong, Z., Polli, J. E., & Shu, Y. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400013t · Cited by 17
Dolberg, A. M., & Reichl, S. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.07.040 · Cited by 17
Renal tubular secretion of pramipexole
Knop, J., Hoier, E., Ebner, T., Fromm, M. F., & Müller, F. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.09.004 · Cited by 16
Mapping of biguanide transporters in human fat cells and their impact on lipolysis
Arner, P., Kulyté, A., Batchelor, K. W., Laurencikiene, J., Livingston, J. N., & Rydén, M. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13395 · Cited by 16
OCT3 promoter haplotype is associated with metformin pharmacokinetics in Koreans
Kwon, E. Y., Chung, J., Park, H., Kim, B. M., Kim, M., & Choi, J. H. (2018) · Scientific Reports · doi:10.1038/s41598-018-35322-6 · Cited by 16
Genetic Variations of the SLC22A4 Gene in Chinese and Indian Populations of Singapore
Toh, D. S. L., Koo, S. H., Limenta, L. M. G., et al. (2009) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.24.475 · Cited by 16
Matsson, E. M., Eriksson, U. G., Palm, J. E., et al. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400341t · Cited by 15
Does bladder outlet obstruction alter the non-neuronal cholinergic system of the human urothelium?
Bschleipfer, T., Weidner, W., Kummer, W., & Lips, K. S. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.04.007 · Cited by 12
Mettral, J. B., Faller, N., Cruchon, S., Sottas, L., Buclin, T., Schild, L., Choong, E., Nahimana, A., & Decosterd, L. A. (2019) · Drug Metabolism Letters · doi:10.2174/1872312813666190207150207 · Cited by 12
Identification and functional characterization of novel MATE1 genetic variations in Koreans
Kim, T. H., Kim, K. H., Park, H., Kim, S., & Choi, J. H. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.03.072 · Cited by 8
Bottalico, B., Noskova, V., Pilka, R., Larsson, I., Domanski, H. A., Casslén, B. G., & Hansson, S. R. (2007) · Molecular Reproduction and Development · doi:10.1002/mrd.20697 · Cited by 7
Physiological and Pathophysiological Regulation of Transporters for Organic Cations
Schlatter, E. (2015) · Springer eBooks · doi:10.1007/978-3-319-23793-0_5 · Cited by 4
Translational Relevance of Animal Models for the Study of Organic Cation Transporter Function
Sabolić, I., Breljak, D., & Smital, T. (2015) · Springer eBooks · doi:10.1007/978-3-319-23793-0_9 · Cited by 1
Cited by
Structural basis of organic cation transporter-3 inhibition
Khanppnavar, B., Maier, J., Herborg, F., Gradisch, R., Lazzarin, E., Luethi, D., Yang, J.-W., Qi, C., Holy, M., Jäntsch, K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34284-8 · Cited by 77
The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy
Puris, E., Fricker, G., & Gynther, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020364 · Cited by 58
Yue, Q., Leng, X., Xie, N., Zhang, Z., Yang, D., & Hoi, M. P. M. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70079 · Cited by 48
Metadata
- Authors
- Koepsell, H.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2020-01
- Volume
- 72
- Issue
- 1
- Pages
- 253-319
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2994850615
- Cited by
- 297
- References
- 550
- FWCI
- 12.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.